Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of Apatinib in Combination With Chemotherapy Versus Chemotherapy Alone for Advanced Ovarian Cancer

NCT03393507 is registered in ClinicalTrials.gov with The People's Hospital of Leshan as lead sponsor.

NCT NCT03393507
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03393507 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of Apatinib in Combination With Chemotherapy Versus Chemotherapy Alone for Advanced Ovarian Cancer
Lead sponsor
The People's Hospital of Leshan
Phase
Phase 2
Overall status
Unknown status
Start date
August 1, 2017
Completion date
December 1, 2019
Enrollment
34 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapeutic toxicity, ovarian cancer